Legend Biotech Corporation
LEGN
$19.91
-$0.58-2.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 387.50M | 305.10M | 306.49M | 272.31M | 255.10M |
| Total Other Revenue | -- | -- | -111.00K | 18.00K | 3.00K |
| Total Revenue | 387.50M | 305.10M | 306.38M | 272.33M | 255.10M |
| Cost of Revenue | 137.40M | 175.90M | 123.46M | 115.31M | 98.00M |
| Gross Profit | 250.10M | 129.20M | 182.92M | 157.02M | 157.10M |
| SG&A Expenses | 96.40M | 90.10M | 101.19M | 87.33M | 80.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 3.20M | 1.00M | -- | -- |
| Total Operating Expenses | 329.80M | 354.90M | 326.98M | 315.78M | 277.00M |
| Operating Income | 57.70M | -49.80M | -20.60M | -43.45M | -21.90M |
| Income Before Tax | 55.50M | -53.10M | -19.60M | -39.07M | -124.80M |
| Income Tax Expenses | 22.30M | 1.20M | 11.22M | 616.00K | 600.00K |
| Earnings from Continuing Operations | 33.20M | -54.30M | -30.82M | -39.69M | -125.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.20M | -54.30M | -30.82M | -39.69M | -125.40M |
| EBIT | 57.70M | -49.80M | -20.60M | -43.45M | -21.90M |
| EBITDA | 61.70M | -47.40M | -17.92M | -41.53M | -19.60M |
| EPS Basic | 0.36 | -0.59 | -0.33 | -0.43 | -1.36 |
| Normalized Basic EPS | 0.19 | -0.18 | -0.07 | -0.13 | -0.42 |
| EPS Diluted | 0.36 | -0.60 | -0.36 | -0.44 | -1.36 |
| Normalized Diluted EPS | 0.18 | -0.18 | -0.07 | -0.13 | -0.42 |
| Average Basic Shares Outstanding | 187.00M | 185.10M | 184.73M | 184.64M | 184.15M |
| Average Diluted Shares Outstanding | 96.90M | 92.55M | 92.37M | 92.32M | 92.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |